CONTACT: RACHEL BALLWEG
Joint Office for Planning, Marketing and Communications
8798 John Pappajohn Pavilion
Iowa City IA 52242
Release: May 9, 2001
Sood receives grants for ovarian cancer research
IOWA CITY, Iowa -- Anil Sood, M.D., University of Iowa assistant professor
of obstetrics and gynecology and a gynecologic oncologist with UI Health Care,
has received two grants for his ovarian cancer research.
The first, a three-year, $240,000 award from the Reproductive Scientist
Development Program was for Sood's grant titled, "Molecular Determinants
of Ovarian Cancer Plasticity." Sood will study whether ovarian tumor
cells form their own blood vessels. If so, Sood said this finding would greatly
enhance patient outcomes, as oncologists would have a new way to treat cancer.
The second grant, a $50,000 award from the Gynecologic Cancer Foundation,
was for Sood's research into the "Role of FAK Expression in Ovarian Cancer
Invasion." FAK is a protein naturally produced in the body that may play
a role in how aggressively ovarian cancer spreads throughout the body. With
this research, Sood hopes to learn whether stopping FAK will help decrease
the aggressiveness of cancer cells.
According to Sood, ovarian cancer is the second most common form of gynecologic
cancer. It is also the most deadly form of gynecologic cancer. For more information
on ovarian cancer, contact the UI Cancer Information Service toll-free at
University of Iowa Health Care describes the partnership between
the UI College of Medicine and the UI Hospitals and Clinics and the patient
care, medical education and research programs and services they provide.